Lupin submits press release

23 Sep 2019 Evaluate

Lupin has informed about submission of a Press Release as regards completion of the US FDA inspection carried out at the Company's Torapur manufacturing (API) facility between September 16 to September 20, 2019. This may be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2320.95 -14.00 (-0.60%)
30-Mar-2026 14:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1775.10
Dr. Reddys Lab 1261.90
Cipla 1230.50
Zydus Lifesciences 881.20
Lupin 2320.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×